Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-03-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고 정정신고' (Correction Report for Stock Option Grant). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the number of shares. This falls under the category of regulatory filings related to capital changes and share-based compensation, which is best classified as a Regulatory Filing (RNS) as it is a specific corporate disclosure to the financial authorities.
2024-03-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report) regarding previously granted stock options. It details changes to the number of shares and the list of recipients. This type of filing, which concerns changes to capital structure or equity-based compensation instruments, is classified as a Regulatory Filing (RNS) as it does not fit into specific categories like Director's Dealing (which is for personal trades) or Share Issue (which is for new capital issuance).
2024-03-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Handok Inc. regarding a correction to a previously reported stock option grant ('주식매수선택권 부여에 관한 신고'). It details specific changes to the number of shares and the list of recipients, which is a standard corporate disclosure regarding capital structure and equity compensation. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance), and it is a formal regulatory disclosure, it falls under the 'Regulatory Filings' category.
2024-03-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously granted stock options, including adjustments to the number of shares and the list of recipients. In the context of financial filings, reports regarding stock option grants, amendments, or capital structure changes that do not fit into specific categories like 'Director's Dealing' (which is for personal trades) are classified as Regulatory Filings (RNS) or general corporate announcements.
2024-03-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and equity-based compensation falls under the 'Share Issue/Capital Change' category.
2024-03-14 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for Handok Inc. It includes the independent auditor's report, financial statements (balance sheet, income statement, etc.), and detailed notes. While it contains an audit report, the inclusion of the full set of financial statements and notes for the fiscal year makes it an Annual Report (10-K equivalent in this context). FY 2023
2024-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.